BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32695279)

  • 1. Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells.
    Bayat AA; Sadeghi N; Fatemi R; Nowroozi MR; Ohadian Moghadam S; Borzuee M; Radmanesh A; Khodadoost M; Sarrafzadeh AR; Zarei O; Rabbani H
    Avicenna J Med Biotechnol; 2020; 12(3):165-171. PubMed ID: 32695279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Cell Surface Fibromodulin Expression and Bladder Carcinoma.
    Bayat AA; Sadeghi N; Salimi A; Fazli G; Nowroozi MR; Ohadian Moghadam S; Radmanesh A; Tabasi M; Sarrafzadeh AR; Zarei O; Rabbani H
    Urol J; 2021 Jul; 19(3):189-195. PubMed ID: 34247360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Therapeutic Implications of Sortilin Expressed on the Surface of Bladder Carcinoma Cells.
    Bayat AA; Sadeghi N; Fazli G; Nowroozi MR; Ohadian Moghadam S; Radmanesh A; Hedayatshodeh M; Sarrafzadeh AR; Zarei O; Ghaemimanesh F; Rabbani H
    Iran J Pathol; 2022; 17(2):174-182. PubMed ID: 35463727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.
    Hojjat-Farsangi M; Ghaemimanesh F; Daneshmanesh AH; Bayat AA; Mahmoudian J; Jeddi-Tehrani M; Rabbani H; Mellstedt H
    PLoS One; 2013; 8(4):e61167. PubMed ID: 23593420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
    Dave H; Anver MR; Butcher DO; Brown P; Khan J; Wayne AS; Baskar S; Rader C
    PLoS One; 2012; 7(12):e52655. PubMed ID: 23285131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
    Balakrishnan A; Goodpaster T; Randolph-Habecker J; Hoffstrom BG; Jalikis FG; Koch LK; Berger C; Kosasih PL; Rajan A; Sommermeyer D; Porter PL; Riddell SR
    Clin Cancer Res; 2017 Jun; 23(12):3061-3071. PubMed ID: 27852699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Down-regulation of receptor-tyrosine-kinase-like orphan receptor 1 suppresses cell growth and enhances apoptosis in human colorectal carcinoma].
    Ma W; He X; Zhang H; Liu T; Feng X; Zhou Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):655-9, 665. PubMed ID: 27126945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
    Shabani M; Naseri J; Shokri F
    Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
    Yang J; Baskar S; Kwong KY; Kennedy MG; Wiestner A; Rader C
    PLoS One; 2011; 6(6):e21018. PubMed ID: 21698301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
    Daneshmanesh AH; Hojjat-Farsangi M; Ghaderi A; Moshfegh A; Hansson L; Schultz J; Vågberg J; Byström S; Olsson E; Olin T; Österborg A; Mellstedt H
    PLoS One; 2018; 13(6):e0198038. PubMed ID: 29856777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.
    Hojjat-Farsangi M; Khan AS; Daneshmanesh AH; Moshfegh A; Sandin A; Mansouri L; Palma M; Lundin J; Österborg A; Mellstedt H
    PLoS One; 2013; 8(10):e78339. PubMed ID: 24205204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies.
    Aghebati-Maleki L; Younesi V; Baradaran B; Abdolalizadeh J; Motallebnezhad M; Nickho H; Shanehbandi D; Majidi J; Yousefi M
    SLAS Discov; 2017 Apr; 22(4):408-417. PubMed ID: 28328317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
    Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
    Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
    Hojjat-Farsangi M; Moshfegh A; Schultz J; Norin M; Olin T; Österborg A; Mellstedt H
    Handb Exp Pharmacol; 2021; 269():75-99. PubMed ID: 34490515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells.
    Simonian M; Haji Ghaffari M; Salimi A; Mirzadegan E; Sadeghi N; Ebrahimnezhad N; Fazli G; Fatemi R; Bayat AA; Milani S; Negahdari B; Rabbani H
    Avicenna J Med Biotechnol; 2022; 14(1):37-45. PubMed ID: 35509360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth by mouse ROR1 specific antibody in a syngeneic mouse tumor model.
    Hassannia H; Amiri MM; Jadidi-Niaragh F; Hosseini-Ghatar R; Khoshnoodi J; Sharifian RA; Golsaz-Shirazi F; Jeddi-Tehrani M; Shokri F
    Immunol Lett; 2018 Jan; 193():35-41. PubMed ID: 29175316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.
    Yin Z; Gao M; Chu S; Su Y; Ye C; Wang Y; Pan Z; Wang Z; Zhang H; Tong H; Zhu J
    Oncotarget; 2017 Nov; 8(55):94210-94222. PubMed ID: 29212222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
    Ida L; Yamaguchi T; Yanagisawa K; Kajino T; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2016 Feb; 107(2):155-61. PubMed ID: 26661061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
    Baskar S; Kwong KY; Hofer T; Levy JM; Kennedy MG; Lee E; Staudt LM; Wilson WH; Wiestner A; Rader C
    Clin Cancer Res; 2008 Jan; 14(2):396-404. PubMed ID: 18223214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells.
    Cetin M; Odabas G; Douglas LR; Duriez PJ; Balcik-Ercin P; Yalim-Camci I; Sayan AE; Yagci T
    Cells; 2019 Mar; 8(3):. PubMed ID: 30832318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.